Polish biotech firm to produce Novavax’s COVID-19 vaccine
The Polish biotechnology company Mabion has signed a preliminary agreement with U.S. drugmaker Novavax to produce its COVID-19 vaccine, Mabion
Continue readingThe Polish biotechnology company Mabion has signed a preliminary agreement with U.S. drugmaker Novavax to produce its COVID-19 vaccine, Mabion
Continue reading